Alan L Rotman
Examiner (ID: 15220)
Most Active Art Unit | 1201 |
Art Unit(s) | 1802, 1612, 1201, 1203, 2899, 1625 |
Total Applications | 2275 |
Issued Applications | 1794 |
Pending Applications | 68 |
Abandoned Applications | 413 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15290421
[patent_doc_number] => 20190388346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING OSTEOARTHRITIS AND PROMOTING CARTILAGE FORMATION
[patent_app_type] => utility
[patent_app_number] => 16/560377
[patent_app_country] => US
[patent_app_date] => 2019-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16560377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/560377 | METHODS AND COMPOSITIONS FOR TREATING OSTEOARTHRITIS AND PROMOTING CARTILAGE FORMATION | Sep 3, 2019 | Abandoned |
Array
(
[id] => 17222009
[patent_doc_number] => 11174500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Methods for purification of messenger RNA
[patent_app_type] => utility
[patent_app_number] => 16/551340
[patent_app_country] => US
[patent_app_date] => 2019-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 24
[patent_no_of_words] => 25794
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16551340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/551340 | Methods for purification of messenger RNA | Aug 25, 2019 | Issued |
Array
(
[id] => 18962935
[patent_doc_number] => 11896674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => SiRNA conjugate, preparation method therefor and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/279145
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 37286
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 348
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279145 | SiRNA conjugate, preparation method therefor and use thereof | Aug 19, 2019 | Issued |
Array
(
[id] => 19011699
[patent_doc_number] => 11918600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Nucleic acid, pharmaceutical composition and conjugate containing nucleic acid, and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/269039
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 41816
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 338
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269039 | Nucleic acid, pharmaceutical composition and conjugate containing nucleic acid, and use thereof | Aug 19, 2019 | Issued |
Array
(
[id] => 17569900
[patent_doc_number] => 11318154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Method of treating
[patent_app_type] => utility
[patent_app_number] => 16/541331
[patent_app_country] => US
[patent_app_date] => 2019-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 5330
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16541331
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/541331 | Method of treating | Aug 14, 2019 | Issued |
Array
(
[id] => 16870012
[patent_doc_number] => 20210163479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => 1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOLE DERIVATIVE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/265794
[patent_app_country] => US
[patent_app_date] => 2019-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265794 | 1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOLE DERIVATIVE COMPOUNDS AND USES THEREOF | Aug 14, 2019 | Pending |
Array
(
[id] => 16932394
[patent_doc_number] => 20210198283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => OPTICALLY ACTIVE BRIDGED PIPERIDINE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/265920
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265920 | OPTICALLY ACTIVE BRIDGED PIPERIDINE DERIVATIVE | Aug 6, 2019 | Pending |
Array
(
[id] => 17256781
[patent_doc_number] => 20210369766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF YEAST-DERIVED POLYSACCHARIDE INDUCING TREG CELL
[patent_app_type] => utility
[patent_app_number] => 17/285253
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285253
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285253 | STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF YEAST-DERIVED POLYSACCHARIDE INDUCING TREG CELL | Jul 28, 2019 | Pending |
Array
(
[id] => 15616095
[patent_doc_number] => 20200078452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => NOVEL GLYCAN CONJUGATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/502844
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502844 | NOVEL GLYCAN CONJUGATES AND METHODS OF USE THEREOF | Jul 2, 2019 | Abandoned |
Array
(
[id] => 17937041
[patent_doc_number] => 11471473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Compositions and methods for treating trichomonas
[patent_app_type] => utility
[patent_app_number] => 16/456532
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5502
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16456532
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/456532 | Compositions and methods for treating trichomonas | Jun 27, 2019 | Issued |
Array
(
[id] => 18518659
[patent_doc_number] => 11708542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Product comprising polysaccharide derivatives
[patent_app_type] => utility
[patent_app_number] => 16/445613
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20855
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445613
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445613 | Product comprising polysaccharide derivatives | Jun 18, 2019 | Issued |
Array
(
[id] => 15895331
[patent_doc_number] => 20200147184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => METHODS FOR INTRODUCING MANNOSE 6-PHOSPHATE AND OTHER OLIGOSACCHARIDES ONTO GLYCOPROTEINS AND ITS APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/439665
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439665
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/439665 | Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof | Jun 11, 2019 | Issued |
Array
(
[id] => 14893803
[patent_doc_number] => 20190290667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => MIXTURES OF HMOs
[patent_app_type] => utility
[patent_app_number] => 16/435949
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16435949
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/435949 | Mixtures of HMOs | Jun 9, 2019 | Issued |
Array
(
[id] => 16443642
[patent_doc_number] => 10835546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => App specific BACE inhibitors (ASBIs) and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/433879
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 34689
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433879 | App specific BACE inhibitors (ASBIs) and uses thereof | Jun 5, 2019 | Issued |
Array
(
[id] => 16991736
[patent_doc_number] => 20210230156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => NOVEL HUMAN DIHYDROOROTATE DEHYDROGENASE (hDHODH) INHIBITORS AND THEIR USE IN TARGETING ONCOLOGICAL DISEASES SENSITIVE TO PYRIMIDINE STARVATION
[patent_app_type] => utility
[patent_app_number] => 16/972456
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972456 | NOVEL HUMAN DIHYDROOROTATE DEHYDROGENASE (hDHODH) INHIBITORS AND THEIR USE IN TARGETING ONCOLOGICAL DISEASES SENSITIVE TO PYRIMIDINE STARVATION | Jun 5, 2019 | Pending |
Array
(
[id] => 16990135
[patent_doc_number] => 20210228555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD OF TREATMENT WITH TRADIPITANT
[patent_app_type] => utility
[patent_app_number] => 16/972391
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972391 | METHOD OF TREATMENT WITH TRADIPITANT | Jun 5, 2019 | Pending |
Array
(
[id] => 19490520
[patent_doc_number] => 12109204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Methods for treating muscular dystrophies
[patent_app_type] => utility
[patent_app_number] => 16/972184
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7609
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972184 | Methods for treating muscular dystrophies | Jun 4, 2019 | Issued |
Array
(
[id] => 14864719
[patent_doc_number] => 20190282601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/430455
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/430455 | PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE | Jun 3, 2019 | Abandoned |
Array
(
[id] => 16703124
[patent_doc_number] => 10953037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Chondroitin sulfate derivative and agent for treating bladder diseases
[patent_app_type] => utility
[patent_app_number] => 16/427875
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 11790
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427875
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427875 | Chondroitin sulfate derivative and agent for treating bladder diseases | May 30, 2019 | Issued |
Array
(
[id] => 16932767
[patent_doc_number] => 20210198656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => METHOD FOR SELECTING POLYNUCLEOTIDES BASED ON THE SIZE IN A GLOBULAR FORM
[patent_app_type] => utility
[patent_app_number] => 17/057164
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057164
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057164 | METHOD FOR SELECTING POLYNUCLEOTIDES BASED ON THE SIZE IN A GLOBULAR FORM | May 23, 2019 | Pending |